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Background: Tissue engineering represents a promising new method for treating
heart valve diseases. The aim of this study was evaluate the importance of
conditioning procedures of tissue engineered polyurethane heart valve prostheses
by the comparison of static and dynamic cultivation methods.
Methods: Human vascular endothelial cells (ECs) and fibroblasts (FBs) were obtained
from saphenous vein segments. Polyurethane scaffolds (n = 10) were primarily seeded
with FBs and subsequently with ECs, followed by different cultivation methods of cell
layers (A: static, B: dynamic). Group A was statically cultivated for 6 days. Group B was
exposed to low flow conditions (t1= 3 days at 750 ml/min, t2= 2 days at 1100 ml/min)
in a newly developed conditioning bioreactor. Samples were taken after static and
dynamic cultivation and were analyzed by scanning electron microscopy (SEM),
immunohistochemistry (IHC), and real time polymerase chain reaction (RT-PCR).
Results: SEM results showed a high density of adherent cells on the surface valves from
both groups. However, better cell distribution and cell behavior was detected in Group
B. IHC staining against CD31 and TE-7 revealed a positive reaction in both groups.
Higher expression of extracellular matrix (ICAM, Collagen IV) was observed in Group B.
RT- PCR demonstrated a higher expression of inflammatory Cytokines in Group B.
Conclusion: While conventional cultivation method can be used for the development
of tissue engineered heart valves. Better results can be obtained by performing a
conditioning step that may improve the tolerance of cells to shear stress. The novel
pulsatile bioreactor offers an adequate tool for in vitro improvement of mechanical
properties of tissue engineered cardiovascular prostheses.
Keywords: Tissue engineering, Heart valve, Polyurethane scaffold, Static cultivation,
Dynamic cultivationBackground
Valve replacement represents the most common surgical therapy for end staged valvular
diseases with an estimated number of 275.000 procedures performed annually worldwide
[1]. The commonly used artificial heart valves are mechanical or biological prostheses.
According to the American Heart Association, mechanical heart valves are recommended
for patient under 60 years of age [2]. However, the increased risk of postoperative
hemorrhage, thromboembolism, and drug-drug interactions affect patients’ quality of life© 2012 Aleksieva et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
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tis, and offer growth potential for pediatric patients [3,4]. However, biological valves are
associated with different major complications such as deterioration of valve structure,
graft calcification, limited durability, and affinity to immunological response [2]. Tissue
engineered heart valves (TEHVs) are a promising approach to overcome the limitations of
conventional heart valve prostheses. Tissue engineering generally aims for the in-vitro
creation of viable neo-tissue indistinguishable from native tissue [5]. Biological and
engineering challenges are focused on three principal components that comprise the
“cell–scaffold–bioreactor system” [6]. An adequate combination of these components
could be the ideal solution for heart valve grafting leading to biocompatibility, non-
thrombogenicity, non-teratogenicity, long-term durability and growth potential of TEHVs
[7]. The aim of this study was to compare static cultivation (SC) and dynamic cultivation
(DC) of endothelial cells (ECs) and fibroblasts (FBs) seeded onto polyurethane heart valve
scaffolds by evaluating cell confluency, extracellular matrix (ECM) formation and inflam-
matory response.Methods
Cell isolation
Cells were isolated from human saphenous vein segments left over from cardiac surgery
interventions. Tissue samples were only taken with the patients’ informed consent and
were further used in an anonymous fashion with no individual-related data. Veins were
cannulated and rinsed with aliquots of 500 ml M199 (Biochrom AG, Berlin, Germany)
supplemented with 1 ml Heparin (5000 i.E.; Ratiopharm GmbH, Ulm, Germany) and 5 ml
Gentamycin (10 mg/ml; Invitrogen AG, Darmstadt, Germany). For EC isolation, segments
were incubated with trypsin/EDTA-solution (10x; Sigma-Aldrich GmbH, Taufkirchen,
Germany) for 25 min at 37°C / 5% CO2. For FBs isolation, veins were subsequently flushed
with 2 mg/ml collagenase type II (Worthington Biochemical Corporation / CellSystems
GmbH, St. Katharinen, Germany) in human serum albumin (200 g/l; Baxter GmbH,
Unterschleißheim, Germany) and incubated for 30 min. Cell suspensions were centrifuged
at 750 rpm for 10 min, and cultured in endothelial cell growth medium (Promocell GmbH,
Heidelberg, Germany) supplemented with 6% FCS (Lonza GmbH, Köln, Germany) and
0.2% Penicillin/Streptomycin (Sigma Aldrich GmbH, Hamburg, Germany) and fibroblast
growth medium (Promocell GmbH, Heidelberg, Germany) supplemented with 11% FCS
and 0.2% Penicillin/Streptomycin, respectively. Medium was changed every second day.
Cells were passaged at confluency.Phenotypic characterization of isolated cells
Morphological and immunocytological analysis were performed to characterize isolated cell
types. ECs were identified by their typical cobblestone morphology. FBs were identified by a
characteristic elongated spindle-shaped appearance with several extensions. For immunocy-
tological verification of ECs and FBs, 35.000 cells/cm2 were cultured in an 8-well culture
slide (BD Bioscience, Bedford, USA) until confluency. Vascular cells were stained against
EC-specific CD31 (0.14 μg/ml; Dianova GmbH, Hamburg, Germany) and FB-specific TE-7
(0.67 μg/ml, Millipore Corporation BioScience Division, Temecula, CA, USA), respectively
according to manufacturer’s protocol using EnVision™ + Dual Link System-HRP (Dako
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The staining procedure was performed at room temperature (RT). After rinsing with
phosphate buffered saline (PBS; Biochrom AG, Berlin, Germany) and blocking for
endogenous peroxidase using 30% H2O2, cells were incubated with the primary antibody
for 30 min. The procedure was completed by incubation with EnVision™ + Dual Link
System- HRP (Dako Deutschland GmbH, Hamburg, Germany) for 30 min; and
AEC- Peroxidase-Substrate (Vector Laboratories, Inc., Burlingame, CA, USA) incubation
for 10 min. Counterstaining was performed using 25% Mayer’s Haemalaun (Merck
KGaA, Darmstadt, Germany) in PBS for 3 min at RT. Controls for non-specific binding
of biotinylated link were performed by excluding the primary antibody. The stained cells
were analyzed using bright field microscopy (Leica DMR microscope, Leica Microsystems
GmbH, Wetzlar, Germany).Fabrication of polyurethane heart valve prosthesis (PHVP)
PHVPs (h = 55 mm, d = 18 mm) were manufactured by ITV-Denkendorf (Denkendorf,
Germany) using a polyurethane spraying technique (patent DE 28 06 030 C2). Randomly
oriented PU fibres formed a sheet with a thickness of 0.3 mm. For seeding purpose, PHVP
was γ-sterilized at 10 kGy according to a certified sterilization procedure.Seeding procedure
PHVPs were sutured to a TeflonW fixation unit (Figure 1a, manufactured in-house) and
were seeded as previously described [8]. Briefly, PHVPs were initially seeded with FBs
(1.5 × 106 cells/cm2) using a 3D- rotating seeding device (Figure 1b; manufactured in-
house) for 24 h (running phase: 2.5 min; holding phase: 30 min), at 37°C / 5% CO2 followed
by a stationary cultivation phase of 6 d (SC group) and 1 d (DC group), respectively at
37°C / 5% CO2 in a glass container (Figure 1c). Cell medium was changed every two days.
Colonization of ECs was analogously performed.Cultivation procedures
For SC, seeded PHVPs (n = 5) were cultured for 6 d at 37°C / 5% CO2 in a glass container.
This procedure is analog the stationary cultivation phase of the seeding procedure shown
in Figure 1c.Figure 1 Seeding of PHVPs. PHVPs were sutured to a TeflonW fixation unit (a) and were consecutively
seeded with FBs and ECs using a 3D-rotating bioreactor (b) for 24 h at 37°C / 5% CO2. After the dynamic
seeding procedure, PHVPs were statically cultivated for 6 d (SC group) and 1 d (DC group), respectively at
37°C / 5% CO2 in a glass container (c). Scale bars: a = 10 mm, b = 20 mm, c = 40 mm.
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endoscopic monitoring unit (Figure 2; EU-Patent pending EP10166094; manufactured
in-house, [9]) for 3 d at 750 ml/min and 2 d at 1100 ml/min medium flow, after FB seed-
ing and after EC seeding. For the conditioning of FB seeded PHVP, fibroblast growth
medium supplemented with 11% FCS and 0.2% Penicillin/Streptomycin were used. FB
+EC seeded PHVP were conditioned using endothelial cell growth supplemented with 6%
FCS and 0.2% Penicillin/Streptomycin. The viscosity of the media was 0.738 mPas ± 0.078
mPas. Cell medium was partially changed every two days. For further analysis, samples
were taken from native as well as from seeded PHVPs after SC and after DC. Samples
were taken from the supravalvular, valvular and subvalvular region of the aortic wall as
well as from the valvular leaflets.Immunohistochemistry (IHC)
Immunohistochemical stainings were performed to differentiate between FB and EC
layers on seeded PHVPs (n = 10). Samples were fixed in 4% formalin (Microcos GmbH,
Garching, Germany) for 10 d, embedded in paraffin and sectioned at 10 μm. Specimen
were deparaffinized in Xylene (Carl Roth GmbH + Co. KG, Karlsruhe, Germany), rehy-
drated by an descending ethanol (Merck KGaA, Darmstadt, Germany) series and permea-
bilized with 0.5% Triton-X (Sigma Aldrich Chemie GmbH, Taufkirchen, Germany) in PBS
for 10 min at RT. Samples for staining against VE-Cadherin, Connexin-43, Fibronectin
and Collagen IV were exposed to 10% Protease (Dako Deutschland GmbH, Hamburg,
Germany) in distilled water (Ampuwa, Fresenius Kabi Deutschland GmbH, Bad Homburg
v.d. H., Germany) for 10 min at RT. For proteolysis of Fibronectin, Collagen IV, and
SMC-Myosin, specimens were boiled in 0.1 mM EDTA buffer (pH = 8.0, Sigma Aldrich
Chemie GmbH, Taufkirchen, Germany) or in Target Retrieval solution (pH = 6.0, Dako
Deutschland GmbH, Hamburg, Germany) for 15 min. For demasking of α- Actin, samples
were boiled in 10 mM Tris/1 mM EDTA solution (pH = 9.0, Sigma Aldrich ChemieFigure 2 DC of seeded PHVPs. Seeded PHVPs in the group DC were conditioned in a pulsatile bioreactor
with an endoscopic monitoring unit [9] for 3 d at 750 ml/min and 2 d at 1100 ml/min. Scale bar = 50 mm.
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using 0.4% H2O2 in PBS, samples were incubated overnight at 4°C with primary antibodies
against VCAM (200 μg/ml), ICAM, SMC-Myosin (0.954 mg/ml; Dako Deutschland
GmbH, Hamburg, Germany), Fibronectin (0.6 mg/ml; Sigma Aldrich Chemie GmbH,
Taufkirchen, Germany), TE-7 (0.1 mg/ml; Millipore GmbH, Schwalbach / Ts.,Germany),
Connexin- 43 (1 μg/ml; Millipore GmbH, Schwalbach/Ts., Germany), VE- Cadherin
(0.2 mg/ml; Beckmann Coulter Inc., Marseille, France), Collagen IV (5.4 mg/ml; Sigma
Aldrich Chemie GmbH, Taufkirchen, Germany), CD31 (0.2 mg/ml; Dako Deutschland
GmbH, Hamburg, Germany) and α- Actin (44 μg/ml; Dako Deutschland GmbH,
Hamburg, Germany). Specimens were incubated with EnVision™ + Dual Link System-HRP
(Dako Deutschland GmbH, Hamburg, Germany), for 10 min, followed by AEC labelling
using AEC-Peroxidase-Substrate Kit (Vector Laboratories, Inc., Burlingame, CA, USA) for
10 min at RT. Counterstaining was performed for 3 min at RT using Mayer’s Hemalaun
(Merck KgaA, Darmstadt, Germany). Controls for non-specific binding of biotinylated link
were performed by excluding primary antibodies. Sections in duplicates of each region
were qualitative observed using bright field microscopy (Leica DMR microscope, Leica
Microsystems GmbH, Wetzlar, Germany) in four fields of vision. The intensity of IHC
staining was analyzed by a minimum of two experts without being blinded to intervention
and were classified as high (+++), medium (++), low (+) and absent (0).Scanning electron microscopy (SEM)
Samples were fixed in 456 ml aqua bidest supplemented with 0.75 ml 1 N hydrochloric
acid (Titrisol, Merck KGaA, Darmstadt, Germany), 43.5 ml glutaraldehyd (Sigma-Aldrich
Chemie GmbH, Steinheim, Germany) and 5.65 g sodium cocodylate trihydrate
(Sigma-Aldrich Chemie GmbH, Steinheim, Germany) at 4°C for 48 h. Dehydration of
fixed specimens was performed by an ascending ethanol series (30%, 50%, 70%, 96%) and
after which the samples were place in 100% acetone (Merck KGaA, Darmstadt, Germany).
After sample drying at the critical point, specimens were coated with gold for 180 s at
10-5 and examined under a scanning electron microscope (Carl Zeiss MikroImaging
GmbH, Göttingen, Germany). Unseeded PHVP specimen served as negative controls.Real time PCR (RT- PCR)
For detection of cytokine expression after SC and DC, RT-PCR was performed according
to manufacturer’s protocols. Briefly, RNA was isolated from samples stored in liquid nitro-
gen using RNAeasy Plus Mini Kit (Qiagen, GmbH, Hilden, Germany). RNA purity and
quantity was photometrically (BioPhotometer, Eppendorf AG, Hamburg, Germany)
assessed. QuantiTect Reverse Transcription Kit (Qiagen, GmbH, Hilden, Germany) was
applied for reverse transcription. Rotor-Gene Q 2plex System (35 cycles; Qiagen GmbH,
Hilden, Germany) and QuantiFast SYBR Green PCR Kit (Qiagen GmbH, Hilden,
Germany) were used to determine IL-1a, IL-6, IL-8, MCP-1, VCAM and GAPDH (Quanti-
Tect Primer Assay, Qiagen GmbH, Hilden, Germany) expression. A standard curve was
generated to determine the primer-dilution. Negative controls without sample material
were included for all PCR measurements. Resulting Ct-values were normalized to the
housekeeping gene GAPDH. PCR-product specificity was verified by melt curve analysis
and gel electrophoresis (FlashGel System, Lonza GmbH, Basel, Switzerland).
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All values are expressed as mean ± standard deviation. Student’s t-test was performed
for comparison of data of unpaired samples. All tests are one-tailed; the probability
value p < 0.05 was considered significant.Results
Cell confluence
Seeding and cultivation of PHVPs were performed as described in materials and methods
section. SEM analysis (Figure 3) of native samples (a) showed randomly orientated fibres.
FB seeded PHVPs revealed a rough confluent cellular coverage after SC (b) and a
smoothed cellular surface after DC (c). FB and EC seeded PHVPs showed a confluent cell
layer after SC (d) and DC (e). In addition, the typical cobblestone morphology indicates
an endothelial layer after SC and DC. Moreover, flow conditions (t1= 3 d at 750 ml/min,
t2= 2 d at 1100 ml/min) influence cell alignment; ECs of the internal side of the PHVPs
were orientated in flow direction (e).Protein expression
IHC examination was performed to compare cellular coverage and ECM formation after
SC and DC. Cell nuclei were stained with haemalaun (purple). As shown in Figure 4,
staining against CD31 (brown; arrows) revealed a positive reaction at both culture condi-
tions (a: SC, b: DC), indicating EC presence. Fibroblasts were detected after SC (c) and
DC (d) in a continuous multilayer by staining against TE-7 (brown, arrows). Comparison
of cellular adhesion molecules demonstrated a lower expression of ICAM after SC
(e; brown, arrows) than after DC (f; brown, arrows). VCAM was also expressed less afterFigure 3 SEM analysis of PUHVs in different processing states. Native PHVPs demonstrate disordered
fibers (a). FB seeded PHVPs revealed a rough confluent cellular coverage after SC (b) and a smoothed
cellular surface after DC (c). FB and EC seeded PUHVs reveal a confluent cell layer with an EC-typical
cobblestone morphology after SC (d). DC results in cell alignment following flow direction (e). These are
representatives of ten independent experiments. Scale bars = 100 μm.
Figure 4 IHC analysis of PUHVs in different processing states. Seeded PUHVs reveal an EC presence
(brown; arrows) after SC (a) and DC (b) SC (c) and DC (d) also result in the formation of fibroblast multilayer
(brown; arrows). A lower expression of ICAM was detected after SC (e; brown, arrows) than after DC
(f; brown, arrows). VCAM was also expressed less after SC (g; brown, arrows) than after DC
(h; brown, arrows). A lower expression of Collagen IV was observed after SC (i; brown, arrows) compared to
DC (j; brown, arrows); VE- Cadherin was also expressed less after SC (k; brown, arrows) than after DC
(l; brown, arrows). Cell nuclei were stained with haemalaun (purple). These are representatives of ten
independent experiments. Scale bars: a, c, e-l = 150 μm, b, d = 50 μm.
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IV was observed after SC (i; brown, arrows) compared to DC (j; brown, arrows);
VE- Cadherin was also expressed less after SC (k; brown, arrows) than after DC
(l; brown, arrows). Controls for non-specific chromogen binding displayed negligible
staining for antigens (data not shown).Gene expression
Figure 5 illustrates the mean values of gene expression in the aortic wall and cusps after
SC and DC. Gene expression was normalized to the expression of the housekeeping gene
GAPDH. The analysis of the aortic wall segments and the cusps of the heart valves pro-
portionately showed equivalent gene expressions after SC and DC for all cytokines. The
analysis of IL-1a and VCAM revealed a negligible expression after SC and DC. In both
cultivation procedures seeding of EC results in a decrease of IL-6 (SC: -66%, DC: -95%)
and MCP-1 (SC: -71%, DC: -56%) expression while IL-8 (SC: + 868%, DC: + 123%) was
expressed to a higher level. The comparison of the SC and DC of FB+EC seeded aortic
wall showed a lower expression of IL-6 (− 59%) and an increase of IL-8 (+ 29%) and
MCP-1 (+ 51%) expression after DC. FB+EC seeded cusps showed a lower expression of
IL-6 (− 72%), an increase of IL-8 (+ 37%) expression and a comparable MCP-1 expression
(+ 10%) after DC compared to SC.
Figure 5 Overview of the PCR results. The bar chart shows the expression of several
cytokines / chemokines in various stages of valve colonization. Gene expression was normalized to the
expression of the housekeeping gene GAPDH. Results are given as the mean values of three independent
experiments ± standard deviation.
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Tissue engineering is an emerging field focused on the development of bioartificial substi-
tues to restore, maintain, or improve tissue function. These applications are the key for the
future treatment of many diseases [10]. Currently, in tissue engineering are several scaffolds
materials under investigation. Synthetic, non-degradable polymers like polyurethane are
mainly characterized by their structural resistance, a three dimensional form with defined
pore sizes, non-immunogenic and anti-thrombotic properties [11]. Within the monomeric
unit, moieties could be substituted by different groups, resulting in versatile properties.
Fabrication of hydrolytic stable PU already led to the development of different implants like
vascular grafts, artificial heart valves and catheters [11,12]. Cells needed for the development
of the tissue engineered heart valves can be obtained from a saphenous vein - vascular cells,
be taken by a bone marrow biopsy - bone marrow stromal cells, from newborn patients,
umbilical cord-derived cells or blood derived endothelial progenitor cells and chorionic
villi-derived cells [13]. In our study, we obtained FBs and ECs from saphenous vein
segments which were no longer required in coronary bypass operations. According to
Schmidt et al., neither the proliferation in a monolayer nor the three-dimensional growth as
tissue engineered constructs is influenced by the age of the cell donor [13], indicating that
adult saphenous vein segments are an adequate cell source for tissue engineering applica-
tions. During the development of a cardiovascular tissue-engineered construct, a large chal-
lenge is the creation of a confluent and stable endothelial cell layer. Complications after the
implantation of artificial grafts are caused in part by the lack of an intact endothelium [14].
The endothelial cell function has been described several times [15,16]. Consigny et al.
showed a better adhesion and shear stress resistance of ECs on prosthetic vessels or heart
valves pre-coated with different ECM proteins [16]. Although this coating improves cell
adhesion, the integrity of the coating is compromised at high flow rates [17]. Another
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mimicking conditions in vivo [8]. In addition, the fibrillar structure of PHVPs is similar to
collagen, the main component of native ECM, and may support cell adhesion. Moreover,
In vivo, cellular phenotype, morphology, and proliferation are affected by mechanical, elec-
trical and chemical signals [18]. If these signals are inappropriate or absent, cells lose their
ability to develop an ECM and to form organized tissues [19]. Thus, the simulation of
physiological conditions, such as shear stress, plays an important role in the development of
tissue engineered constructs [20,21]. For the fabrication of vascular grafts, Syedain et al. and
Tschoeke et al. demonstrated the expression of ECM components by human dermal fibro-
blast and ovine arterial myofibroblasts in fibrin gel under dynamic culture conditions gener-
ated by a pulsed flow-stretch bioreactor and a pulsatile bioreactor, respectively [22,23].
In heart valve fabrication, bioreactors for tissue formation under dynamic culture condi-
tions have been reported several times [24,25]. Ramaswamy et al. described a large collagen
mass production after the use of simulated pulmonary artery conditions using an organ-
level heart valve bioreactor [26]. The stimulation of human dermal fibroblasts seeded onto a
decellularized porcine matrix by a pneumatic flow bioreactor, resulting in the synthesis of
ECM proteins was shown by Zeltinger et al. [27]. Mol et al. demonstrated that dynamically
strained leaflets reveal a more homogenous and denser cellular coverage than leaflets
exposed to pre-strain only [25]. This is in line with results, generated in our study: SC and
DC results in a confluent cell layer. In this context, numerous studies have reported the
behaviour of ECs to flow shear stress in-vitro. ECs are constantly subjected to hemodynamic
forces, including shear stresses that induce various functional changes in vascular endothe-
lium. Initially, it was found that exposure of ECs to elevated shear stresses in-vitro caused
them to align in the direction of flow [28]. In our study, after DC ECs were also orientated
into flow direction after DC, indicating the adaption to shear stress. The higher expression
of cellular adhesion molecules after DC illustrates the intensified formation of cell con-
necting molecules, due to the pulsatile conditioning process. Moreover, a higher expression
of Collagen IV, VE-Cadherin and Fibronectin was observed after DC indicating the forma-
tion of an ECM, essential for tissue and organ morphogenesis, maintenance, and recon-
struction following injury in association with constructive tissue remodeling [29]. However,
shear stress as a result of the DC provoked a higher cytokine expression compared to SC
[30]. EC are able to sense changes in the shear stress or flow forces and respond, for
instance, by expression of pro-inflammatory cytokines [31]. These cytokines and/or chemo-
kines play key roles in mediating inflammatory reactions [32]. Gerszten et al. already
concluded that cytokines are important modulators of monocyte-endothelial interactions
under flow conditions [33]. McGill et al. demonstrated that consecutive seeding of heart
valve scaffolds with FB and EC results in a less inflammatory response after DC than singly
seeding with EC [34]. Chiu et al. reported that a coculture of vascular ECs with vascular
smooth muscle cells induces the expression of ICAM-1, VCAM-1, and E-selectin genes in
ECs in the static condition, whereas the application of shear stress to ECs inhibits these
coculture-induced gene expressions [35]. Our analysis of IL-1a and VCAM expression
revealed a negligible expression after SC and DC of FB and EC seeded scaffolds. These
findings are also described by McHale et al. and Murui et al., indicate a lower risk of inflam-
matory response and arteriosclerosis [36,37]. While IL-1a and VCAM were expressed to a
lower level after DC, the expression of IL-8 increased after DC. Several studies have shown
a correlation between IL-8 expression, arteriosclerosis and coagulation which is thought to
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barrier [34,38]. However, not only shear stress, but rather cell isolation from biopsies
provokes stress symptoms. For example, the process of human islet isolation triggers a
cascade of stressful events in the islets of Langerhans involving the production of
proinflammatory molecules. Two of the major pathways responsible for cellular responses
to stress, already occurs in pancreatic cells during the isolation procedure. The production
and release of IL-6, IL-8 and MCP-1, were observed days after the isolation procedure in
isolated purified islets [39]. Therefore, the next step will be long-term conditioning of our
TEHVs for a better adaption of cells to shear stress after isolation and cultivation proce-
dure and consequently to reduce inflammatory response.Conclusions
In conclusion, we demonstrate that DC is more effective than SC in generating TEHVs.
DC supports ECM formation and homogeneity of the cellular coverage. The novel
pulsatile bioreactor provides a strong tool for dynamic pre-conditioning of TEHVs.
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